Cargando…
Subcutaneous Levetiracetam Application Sustains Therapeutic Drug Levels
We report on a patient suffering from seizures caused by cerebral metastases of adenocarcinoma of the lung. Initially, the patient was treated effectively with oral levetiracetam. As the disease progressed, oral intake was no longer possible. Since levetiracetam had controlled the patient's sei...
Autores principales: | Westphal, Sophia, Hertler, Caroline, Blum, David, Schettle, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241392/ https://www.ncbi.nlm.nih.gov/pubmed/34223515 http://dx.doi.org/10.1089/pmr.2020.0119 |
Ejemplares similares
-
Subcutaneous Olanzapine at the End of Life in a Patient with Schizophrenia and Dysphagia
por: Hindmarsh, Jonathan, et al.
Publicado: (2020) -
Challenges in the Management of Home-Based Care Experienced by a Caregiver with Autism Spectrum Disorder
por: Ohsawa, Sayaka, et al.
Publicado: (2021) -
Drug–drug interaction between levetiracetam and non-vitamin K antagonist anticoagulants
por: Mathy, François-Xavier, et al.
Publicado: (2019) -
Early, Patient-Centered, and Multidisciplinary Approach in Newly Diagnosed Multiple Myeloma: What Are We Talking About? A Case Description and Discussion
por: Sørensen, Jonas, et al.
Publicado: (2022) -
Advances in Cardiopulmonary Life-Support Change the Meaning of What It Means to be Resuscitated
por: Avant, Leslie C., et al.
Publicado: (2020)